32228-020-01 : NDC 2026 Code

32228-020-01 : Bevacizumab-adcd ( )

Additionally :

You can get information about “32228-020-01” NDC code in 32228-020-01 in HTML format

HTML | 32228-020-01 in TXT (Plain Text) format

TXT | 32228-020-01 in PDF (Portable Document Format)

PDF | 32228-020-01 in XML format

XML formats.

NDC Code : 32228-020-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "32228-020-01",
    "PackageDescription": "4 mL in 1 VIAL (32228-020-01) ",
    "NDC11Code": "32228-0020-01",
    "ProductNDC": "32228-020",
    "ProductTypeName": "DRUG FOR FURTHER PROCESSING",
    "ProprietaryName": null,
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Bevacizumab-adcd",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": null,
    "StartMarketingDate": "20230403",
    "EndMarketingDate": null,
    "MarketingCategoryName": "DRUG FOR FURTHER PROCESSING",
    "ApplicationNumber": null,
    "LabelerName": "CELLTRION, Inc",
    "SubstanceName": "BEVACIZUMAB-ADCD",
    "StrengthNumber": "100",
    "StrengthUnit": "mg/4mL",
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Unfinished",
    "LastUpdate": "2025-05-01",
    "PackageNdcExcludeFlag": null,
    "ProductNdcExcludeFlag": null,
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "30-APR-25",
    "EndMarketingDatePackage": null,
    "SamplePackage": null
  }
}